Abstract
Purpose: To present a review of stroke and myocardial infarction following intravitreal anti-VEGF treatment. Cases and Method: This retrospective study was made on 960 patients who received intravitreal injection of anti-VEGF during the past 6 years at Toyama University Hospital. The series comprised 593 males and 367 females. The age averaged 70.9 years at the start of treatment. Results: Cerebral stroke developed in 11 cases (l.2%) and myocardial infarction developed in 3 cases (0.3%). Stroke of myocardial infarction developed in 5 cases within one month of vitreal injection of aflibercept as anti-VEGF. Conclusion: Stroke or myocardial infarction developed in 1.4% of cases receiving intravitreal anti-VEGF. Aflibercept appeared to be followed by cerebral or myocardial accidents within one month of treatment.
| Original language | English |
|---|---|
| Pages (from-to) | 551-557 |
| Number of pages | 7 |
| Journal | Japanese Journal of Clinical Ophthalmology |
| Volume | 71 |
| Issue number | 4 |
| State | Published - 2017/04 |
ASJC Scopus subject areas
- Ophthalmology